| 1-R15-EB035866-01 |
Mitochondrial-targeting Exosomes for Neuroinflammation |
Lanrong Bi |
Michigan Technological University |
| 5-R01-EB031904-04 |
Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13 |
Wilson Wong |
Boston University (Charles River Campus) |
| 1-R21-EB034346-01A1 |
Next generation of delivery platform for Prime editors based on an RNA vector for Sickle cell disease: the “all-in-one” vector |
Patricia Devaux |
Mayo Clinic Rochester |
| 5-R01-EB033676-03 |
Next generation transposon vectors for genome engineering |
Matthew Wilson |
Vanderbilt University Medical Center |
| 5-R21-EB032609-02 |
Novel optogenetic tool for noninvasive neuronal inhibition |
Mark Gomelsky |
University of Wyoming |
| 5-R21-EB035261-02 |
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation |
Connie Wu |
University of Michigan at Ann Arbor |
| 7-R01-EB031957-04 |
Programmable gene integration and cell engineering with CRISPR-directed integrases |
Omar Abudayyeh |
Brigham And Women'S Hospital |
| 5-R21-EB033981-03 |
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding |
Oded Regev |
New York University |
| 5-R01-EB031830-04 |
Reprogramming Exosomes for Biomedical Applications |
Yong Zhang |
University of Southern California |
| 1-R21-EB036277-01 |
Ribozyme-mediated killing of cells harboring cancer driver mutations |
André Leier |
University of Alabama at Birmingham |
